Cargando…
Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways
OBJECTIVE: Human oral squamous cell carcinoma (OSCC) is a major cause of mortality and morbidity worldwide. There is an urgent need to identify bioactive molecules and potential target genes that could inhibit carcinogenesis for OSCC therapy. Fisetin (3,7,3′,4′-tetrahydroxyflavone), a naturally occu...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049269/ https://www.ncbi.nlm.nih.gov/pubmed/32158195 http://dx.doi.org/10.2147/DDDT.S229270 |
_version_ | 1783502406456180736 |
---|---|
author | Li, Yanshu Jia, Shiheng Dai, Wei |
author_facet | Li, Yanshu Jia, Shiheng Dai, Wei |
author_sort | Li, Yanshu |
collection | PubMed |
description | OBJECTIVE: Human oral squamous cell carcinoma (OSCC) is a major cause of mortality and morbidity worldwide. There is an urgent need to identify bioactive molecules and potential target genes that could inhibit carcinogenesis for OSCC therapy. Fisetin (3,7,3′,4′-tetrahydroxyflavone), a naturally occurring flavonoid, has been previously shown to have anti-proliferative activities in OSCC; however, its molecular mechanism is unknown. METHODS: Colony formation, cell viability, Boyden chamber, wound healing, and tumor xenograft assays were used to detect the impact of fisetin on OSCC cells in vitro and in vivo. Western blot analysis was used to examine the corresponding protein expression. RESULTS: Fisetin treatment significantly inhibited proliferation and promoted apoptosis by repressing PAK4 expression. Moreover, fisetin treatment attenuated cell migration by blocking PAK4 signaling pathways. In addition, the tumor xenograft showed anti-tumor growth effects of fisetin exposure in vivo. CONCLUSION: Fisetin may represent a potential therapeutic strategy for human OSCC by targeting PAK4 signaling pathways. |
format | Online Article Text |
id | pubmed-7049269 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-70492692020-03-10 Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways Li, Yanshu Jia, Shiheng Dai, Wei Drug Des Devel Ther Original Research OBJECTIVE: Human oral squamous cell carcinoma (OSCC) is a major cause of mortality and morbidity worldwide. There is an urgent need to identify bioactive molecules and potential target genes that could inhibit carcinogenesis for OSCC therapy. Fisetin (3,7,3′,4′-tetrahydroxyflavone), a naturally occurring flavonoid, has been previously shown to have anti-proliferative activities in OSCC; however, its molecular mechanism is unknown. METHODS: Colony formation, cell viability, Boyden chamber, wound healing, and tumor xenograft assays were used to detect the impact of fisetin on OSCC cells in vitro and in vivo. Western blot analysis was used to examine the corresponding protein expression. RESULTS: Fisetin treatment significantly inhibited proliferation and promoted apoptosis by repressing PAK4 expression. Moreover, fisetin treatment attenuated cell migration by blocking PAK4 signaling pathways. In addition, the tumor xenograft showed anti-tumor growth effects of fisetin exposure in vivo. CONCLUSION: Fisetin may represent a potential therapeutic strategy for human OSCC by targeting PAK4 signaling pathways. Dove 2020-02-25 /pmc/articles/PMC7049269/ /pubmed/32158195 http://dx.doi.org/10.2147/DDDT.S229270 Text en © 2020 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Yanshu Jia, Shiheng Dai, Wei Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways |
title | Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways |
title_full | Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways |
title_fullStr | Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways |
title_full_unstemmed | Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways |
title_short | Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways |
title_sort | fisetin modulates human oral squamous cell carcinoma proliferation by blocking pak4 signaling pathways |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049269/ https://www.ncbi.nlm.nih.gov/pubmed/32158195 http://dx.doi.org/10.2147/DDDT.S229270 |
work_keys_str_mv | AT liyanshu fisetinmodulateshumanoralsquamouscellcarcinomaproliferationbyblockingpak4signalingpathways AT jiashiheng fisetinmodulateshumanoralsquamouscellcarcinomaproliferationbyblockingpak4signalingpathways AT daiwei fisetinmodulateshumanoralsquamouscellcarcinomaproliferationbyblockingpak4signalingpathways |